The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Anti‐dsdna and complement profiles as prognostic guides in systemic lupus erythematosus
Abstract
Antibodies to dsDNA, tested with circular DNA in the Farr assay, are specific for systemic lupus erythematosus. A longitudinal study showed a clear relation between the clinical state, the anti‐dsDNA titer (expressed in units), and the C1q and C3 levels: when anti‐dsDNA levels remained high, no exacerbations were observed. A sharp drop in anti‐dsDNA, usually preceded by a rise, was related to a serious exacerbation. Only during the exacerbation when both C1q and C3 were very low was renal involvement seen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunologic Factors and Clinical Activity in Systemic Lupus Erythematosus
Schur, P. H., & Sandson, J. (1968) · New England Journal of Medicine · doi:10.1056/nejm196803072781004 · Cited by 587
Aarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
Self-citationMeasurement of Serum DNA-Binding Activity in Systemic Lupus Erythematosus
Pincus, T., Schur, P. H., Rose, J. A., Decker, J. L., & Talal, N. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909252811304 · Cited by 441
Profiles of Antinuclear Antibodies in Systemic Rheumatic Diseases
Notman, D. D., KURATA, N., & TAN, E. M. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-464 · Cited by 365
Properties of bacteriophage PM2: A lipid-containing bacterial virus
Espejo, R. T., & Canelo, E. S. (1968) · Virology · doi:10.1016/0042-6822(68)90094-9 · Cited by 335
Significance Of Persisting Serologic Abnormalities In SLE
Lightfoot, R. W., & Hughes, G. R. V. (1976) · Arthritis & Rheumatism · doi:10.1002/art.1780190501 · Cited by 95
Locker, J. D., Medof, M. E., Bennett, R. M., et al. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.118.2.694 · Cited by 89
Immunology of DNA. IV. Quantitative aspects of the Farr assay
Aarden, L., Lakmaker, F., & de Groot, E. R. (1976) · Journal of Immunological Methods · doi:10.1016/0022-1759(76)90143-5 · Cited by 81
Self-citationWinfield, J. B., & Davis, J. S. (1974) · Arthritis & Rheumatism · doi:10.1002/art.1780170202 · Cited by 79
Immunology of DNA. II. The effect of size and structure of the antigen on the farr assay
Aarden, L. A., Lakmaker, F., & Feltkamp, T. E. W. (1976) · Journal of Immunological Methods · doi:10.1016/0022-1759(76)90005-3 · Cited by 78
Self-citation
Cited by
Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
Tan, E. M. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60641-0 · Cited by 1,514
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Mechanisms of killing by anti-CD20 monoclonal antibodies
Glennie, M. J., French, R. R., Cragg, M. S., & Taylor, R. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.151 · Cited by 515
Kavanaugh, A., Tomar, R., Reveille, J., Solomon, D. H., & Homburger, H. A. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0071-gfcuot · Cited by 443
C1q and Systemic Lupus Erythematosus
Walport, M. J., Davies, K. A., & Botto, M. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80032-6 · Cited by 393
Bastian, H. M., Roseman, J. M., Mcgwin, G., Alarcón, G. S., Friedman, A. W., Fessler, B. J., Baethge, B. A., Reveille, J. D., & Lumina Study Group (2002) · Lupus · doi:10.1191/0961203302lu158oa · Cited by 360
The use of laboratory tests in the diagnosis of SLE
Egner, W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.6.424 · Cited by 316
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
Jeltsch-David, H., & Muller, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.148 · Cited by 304
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
C1q, Autoimmunity and Apoptosis
BOTTO, M. (2002) · Immunobiology · doi:10.1078/0171-2985-00141 · Cited by 289
Origins of anti-DNA autoantibodies.
Schwartz, R. S., & Stollar, B. D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111704 · Cited by 287
Tan, E. M., Chan, E. K. L., Sullivan, K. F., & Rubin, R. L. (1988) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(88)90066-9 · Cited by 271
Kramers, C., Hylkema, M. N., van Bruggen, M. C., van de Lagemaat, R., Dijkman, H. B., Assmann, K. J., Smeenk, R. J., & Berden, J. H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117371 · Cited by 266
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests
Kavanaugh, A. F., Solomon, D. H., & The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2002) · Arthritis Care & Research · doi:10.1002/art.10558 · Cited by 225
Swaak, T., & Smeenk, R. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.4.245 · Cited by 89
Anti-dsDNA: choice of assay in relation to clinical value
Smeenk, R. J. T., van den Brink, H. G., Brinkman, K., Termaat, R. M., Berden, J. H. M., & Swaak, A. J. G. (1991) · Rheumatology International · doi:10.1007/bf00304496 · Cited by 75
“With respect to the Farr assay, Swaak et al. have found that major disease symptoms in SLE patients only occurred during a rapid decrease of the anti-dsDNA level [ 44 ].”
ResultSelf-citationBecker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40900-3 · Cited by 75
Antico, A., Platzgummer, S., Bassetti, D., Bizzaro, N., Tozzoli, R., Villalta, D., & Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine (SIMeL) (2010) · Lupus · doi:10.1177/0961203310362995 · Cited by 70
Andrejevic, S., Jeremic, I., Sefik-Bukilica, M., Nikolic, M., Stojimirovic, B., & Bonaci-Nikolic, B. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2330-3 · Cited by 56
Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity
Smeenk, R. J. T., Van Rooijen, A., & Swaak, T. J. G. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90438-3 · Cited by 40
Detection of antibodies to dsDNA: an overview of laboratory assays
Rouquette, A., & Desgruelles, C. (2006) · Lupus · doi:10.1191/0961203306lu2324oa · Cited by 39
Žigon, P., Lakota, K., Čučnik, S., Švec, T., Ambrožič, A., Sodin-Šemrl, S., & Kveder, T. (2011) · Croatian Medical Journal · doi:10.3325/cmj.2011.52.694 · Cited by 19
Yuan, W., Cao, H., Wan, P., Shi, R., Zhou, S., & Zheng, J. (2019) · Lupus · doi:10.1177/0961203319877243 · Cited by 15
Kumar, V., Krasny, S., & Beutner, E. H. (1985) · Immunological Investigations · doi:10.3109/08820138509076144 · Cited by 9
Metadata
- Authors
- Swaak, A. J. G., Aarden, L. A., Statius Eps, L. W. V., & Feltkamp, T. E. W.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1979-03
- Volume
- 22
- Issue
- 3
- Pages
- 226-235
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2030070609
- Cited by
- 284
- References
- 19
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.